-

Agilent Announces New, Innovative 7850 ICP-MS System

Smart functions and tools optimize productivity and efficiency

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced a new ICP-MS instrument, the Agilent 7850 ICP-MS System, that provides new smart tools to minimize common time traps that can affect ICP-MS analysis workflows.

Building on decades of innovation, the 7850 ICP-MS combines market-leading performance with new smart software features that bring advanced capabilities to the routine ICP-MS laboratory. The new 7850 provides solutions that enable customers to be more productive and efficient while ensuring high quality results.

“The biggest impact of this new system will be in helping our customers avoid common time traps that can result in wasted time, higher costs, lower productivity, and ultimately staff stress and potential turnover,” said Keith Bratchford, vice president, and general manager, Agilent Spectroscopy. “The smart tools and streamlined workflows of the 7850 simplify ICP-MS analysis, assisting customers in each step of their typical sample analysis.”

“These smart features are particularly helpful for less experienced users who are often tasked with operating the ICP-MS in small- to medium-sized contract testing labs,” Bratchford added.

The costs to a lab that fails to recognize or address common time traps are not just limited to lost time and revenue. Unnecessary method setup steps, instrument checks, manual data reviews, and the need for sample reanalysis also place more pressure on busy lab staff. This workload can impact sample turnaround time and the quality of the results that customers expect—putting a laboratory’s reputation at risk.

The 7850 uses a configuration that is optimized to handle the range of sample types measured in typical ICP-MS applications while ensuring data is free from common sources of error. Smart tools help customers through the initial setup of the instrument and required methods, and guides users through the typical ICP-MS workflow that is used to measure sample batches. Smart functions also assist with data review, eliminating the need for an ICP-MS expert to perform the important step of verifying data quality.

The new 7850 is the smart way to ensure fast setup and streamlined analysis for great results in typical ICP-MS applications.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics and applied chemical markets delivering insight and innovation toward improving the quality of life. Agilent instruments, software, services, solutions and people provide trusted answers to customers' most challenging questions. The company generated revenue of $5.34 billion in fiscal 2020 and employs 16,400 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter, and Facebook.

Contacts

Naomi Goumillout
Agilent Technologies
+1.781.266.2819
naomi.goumillout@agilent.com

Agilent Technologies Inc.

NYSE:A
Details
Headquarters: Santa Clara, California, USA
CEO: Padraig McDonnell
Employees: 18000
Organization: PUB

Release Versions

Contacts

Naomi Goumillout
Agilent Technologies
+1.781.266.2819
naomi.goumillout@agilent.com

More News From Agilent Technologies Inc.

Agilent to Participate in 9th Annual Evercore Healthcare Conference

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that the company will participate in the upcoming 9th Annual Evercore Healthcare Conference. Agilent management is scheduled to participate in a fireside chat from 10 a.m. to 10:50 a.m. EST on Tuesday, Dec. 1, 2026, in Coral Gables, Florida. A live audio webcast and replay of the presentation will be available through Agilent’s Investor Relations website. About Agilent Technologies Agilent Technologies Inc...

Agilent Expands Tumor Profiling Portfolio with SureSelect Cancer Research Pan Heme

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the SureSelect Cancer Research Pan Heme, a hybrid capture-based next-generation sequencing (NGS) research solution for comprehensive genomic profiling of hematologic malignancies. Developed in collaboration with experts at Roswell Park Comprehensive Cancer Center, the solution integrates DNA and RNA profiling, automated sample preparation and bioinformatics in a streamlined workflow. The introduction of Su...

Agilent Completes Acquisition of Proscia

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the successful completion of its previously announced acquisition of Proscia®, a leading provider of digital-pathology software for clinical and life-sciences customers. Under the terms of the transaction, Agilent acquired Proscia for $240 million in cash at closing, with up to an additional $30 million payable based on the achievement of future performance milestones. Following the closing of the transact...
Back to Newsroom